Article

An American Journal of Managed Care® Symposium: Examining Treatment Advancements in Psoriasis and Psoriatic Arthritis

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Steven Daveluy, MD, dermatologist, Wayne State University
April Armstrong, MD, MPH, chief of dermatology, UCLA
April Armstrong, MD, MPH, chief of dermatology, UCLA
Related Content
Pediatric Psoriasis | Image Credit: Evgeniya Primavera - stock.adobe.com .jpeg
September 16th 2025

Review Reveals the Hidden Burden of Psoriasis on Children, Families

Pearl Steinzor
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
September 16th 2025

Psoriasis as an Inflammatory Disease, and What’s Changed Over Time

Doctor examines patient with psoriasis rash | ARTFULLY-79 - stock.adobe.com
September 16th 2025

Real-World Data Show 12-Month Drug Survival Rates Among Anti-TNF Biosimilars in Psoriasis, PsA

Deana Ferreri, PhD
Adalimumab | Image credit: luchschenF - stock.adobe.com
September 16th 2025

Infection Risk Higher in HS Compared With Psoriasis With Adalimumab

Pearl Steinzor
Psoriatic arthritis | Image credit: Oporty786 - stock.adobe.com
September 16th 2025

The Totality of Evidence of Ustekinumab Biosimilar SB17

Deana Ferreri, PhD
Psoriasis treatment concept | Sviatlana - stock.adobe.com
September 16th 2025

Beyond the Surface: How New Therapies, Patient-Centered Care Are Changing Psoriasis Outcomes

Pearl Steinzor

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo